20298 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin Lactones
BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF
#602COMPOSITION FOR TREATING HEPATITIS B, AND METHOD FOR EVALUATING REPLICATION ACTIVITY OF HEPATITIS B VIRUS
#603Angiopoietin-based interventions for treating cerebral malaria
#604COMPOSITIONS THAT INCLUDE ANTHOCYANIDINS AND METHODS OF USE
#605NON-STEROIDAL SELECTIVE GLUCOCORTICOID RECEPTOR AGONISTIC MODULATORS (SEGRAMs) AND USES THEREOF
#606Pharmaceutical composition containing Ginkgolide B and ADP receptor antagonist, preparation method thereof and use thereof
#607Challenge test for diagnosing subtypes of ASD
#608Method of identifying ASD phenotype 1 patients
#609Treatment of a subtype of ASD
#610Extract of andrographis paniculata for cognitive enhancement
#611Prevention and treatment of viral infections
#612METHODS AND COMPOSITIONS FOR TREATMENT OF RETT SYNDROME
#613Use of a composition for lowering cholesterol level in a mammal, a method for its preparation and a product and a food additive comprising said composition
#614Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract
#615Soft Chewable Pharmaceutical Product
#616Soft Chewable Pharmaceutical Products
#617Use of acyl-homoserine lactone derivatives as anti-thrombotic agents
#618Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
#619LYMPH DIRECTING PRODRUGS
#620Inhibitor of inflammasome activation
#621Anti-fungal compounds
#622Combined organ and hematopoietic cells for transplantation tolerance of grafts
#623Hepatitis B antiviral agents
#624THERAPEUTIC EFFECTS OF BRYOSTATINS, BRYOLOGS, AND OTHER RELATED SUBSTANCES ON HEAD TRAUMA-INDUCED MEMORY IMPAIRMENT AND BRAIN INJURY
#625Combined organ and hematopoietic cells for transplantation tolerance of grafts
#626Andrographolide treats progressive forms of multiple sclerosis
#627Derivatives of korormicin useful as antibiotics
#628Ginkgolide B derivative and preparation method and use thereof
#629Feijoa fruit extract
#630ENHANCED IMMUNE RESPONSE UPON TREATMENT WITH NITRIC OXIDE
#631PIM kinase inhibitors in combination with RNA splicing modulators/inhibitors for treatment of cancers
#632Composition and method for treatment of neurodegenerative diseases
#633Veterinary composition comprising imidacloprid, moxidectin and praziquantel for cutaneous topical application (spot on), for the treatment and prevention of ecto and endoparasitoses affecting dogs
#634USING FATTY ACID SYNTHASE INHIBITORS TO TREAT FIBROSIS
#635Antitumor arylnaphthalene ligand glycosides
#636METHODS OF MODULATING PROTEIN EXOCYTOSIS AND USES OF SAME IN THERAPY
#637Molecule with anti-cancer activity
#638Glucose conjugates of triptolide, analogs and uses thereof
#639NOVEL CLASS OF COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE
#640Quantification and preparation of pharmaceutical grade cantharidin
#641Podophyllotoxin derivative with 4-position nitrogen substitution and preparation method and application thereof
#642Modulators of zinc activated cation channel
#643Method of treating refractory rheumatoid arthritis associated with p53 mutation
#644Use of butylidenephthalide
#645Methods for treating obesity
#646Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts
#647Combinations for the treatment of cancer
#648Methods and compositions for treating obesity and/or diabetes and for identifying candidate treatment agents
#649Method for treating pulmonary fibrosis comprising application of dimethylamino micheliolide
#650Hypotonic microbicidal formulations and methods of use
#651Use of hibiscus acid and derivatives thereof as antimicrobials against antibiotic-resistant and non-antibiotic-resistant microorganisms
#652Anti-LAG3 antibodies and antigen-binding fragments
#653Multikinase inhibitors for use in the treatment of cancer
#654Methods for treating angiogenesis related disorder
#655COMPOSITIONS AND METHODS FOR TREATING LUNG DISEASES
#656Tricyclic prodrugs
#657Combined organ and hematopoietic cells for transplantation tolerance of grafts
#658Donor organ pre-treatment formulation
#659COMPOSITIONS AND METHODS FOR IMPROVING HEART FUNCTION AND TREATING HEART FAILURE
#660Protocol for treatment of lupus nephritis
#661Methods and pharmaceutical compostions for treating rhabdomyolysis
#662USING COLIPASE INHIBITORS TO TREAT PANCREATITIS
#663Ophthalmic pharmaceutical compositions and uses relating thereto
#664Uses of butylidenephthalide
#665Methods of treating hearing loss
#666Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
#667Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
#668Methods for detection and eradication of myeloid leukemia stem cells
#669Transplantation therapies
#670EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
#671Folate-conjugated molecules for delivery of toxic small molecule inhibitors to cancer cells and methods of use
#672USE OF FLAXSEED AND FLAXSEED DERIVATIVES FOR TREATMENT OF NEUROLOGICAL DISORDERS AND VIRAL DISEASES
#673Edible energy composition
#674Compositions and methods for treating cancer
#675Use of acyl-homoserine lactone derivatives as anti-thrombotic agents
#676Conjugate of memantine and arctigenin, and composition and use thereof
#677COMPOSITIONS AND METHODS FOR PARKINSON'S DISEASE THERAPY
#678TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS
#679Use of avermectin derivative for increasing bioavailability and efficacy of macrocyclic lactones
#680TREATMENT OF AUTOIMMUNE DISEASES
#681C-Myc as a biomarker for tumor sensitivity to treatment with RNA polymerase II inhibition
#682Target for treating hepatitis B virus
#683Derivative of lactone A
#684Compositions for improved NRF2 activation and methods of their use
#685Lymph directing prodrugs
#686Combined organ and hematopoietic cells for transplantation tolerance of grafts
#687USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDGs) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION DAMAGE
#688NEUROTRANSMITTER AND BRAIN MODULATING ORAL DELIVERY SYSTEM FOR ENHANCEMENT OF COGNITIVE FUNCTIONS AND ENERGY
#689Pharmaceutical composition containing Bay 11-7082, parthenolide or a combination thereof for the treatment of obesity or cardiovascular diseases
#690Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
#691Angiopoietin-based interventions for treating cerebral malaria
#692Monoacylglycerols for use in conjunction with a lipase inhibitor and/or diets low in fat and/or calories
#693Antimicrobial fusion peptides
#694Combined organ and hematopoietic cells for transplantation tolerance of grafts
#695TREATMENT OF NEURODEGENERATIVE CONDITIONS USING PKC ACTIVATORS AFTER DETERMINING THE PRESENCE OF THE APOE4 ALLELE
#696Compounds for use in treating or preventing cancerous diseases
#697Compositions and Methods for Treating Multi-Drug Resistant Malaria
#698OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES RELATING THERETO
#699Use of butylidenephthalide (Bdph), method of using the same, and method for preparing pharmaceutical composition containing the same
#700Combined organ and hematopoietic cells for transplantation tolerance of grafts
#701Combined organ and hematopoietic cells for transplantation tolerance of grafts
#702Chemical entities that kill senescent cells for use in treating age-related disease
#703PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF
#704FORMULATION COMPRISING PARTICLES AND A LIPASE INHIBITOR
#705N-sulfonyl homoserine lactone derivatives, preparation method and use thereof
#706Glucagon-like peptide 1 modulator and uses thereof
#707Microspheres containing anthelmintic macrocyclic lactones
#708GFRalpha1 AS A BIOMARKER FOR CISPLATIN-INDUCED CHEMORESISTANCE AND METASTASIS
#709Drug Combinations For the Treatment of HIV
#710Treprostinil derivative compounds and methods of using same
#711Acetogenin molecules having antiplatelet and/or antithrombic activities, and methods and compositions thereof
#712Ether analogues of galiellalactone
#713Non-aromatic difluoro analogues of resorcylic acid lactones
#714Synthetic substrates for enzymes that catalyze reactions of modified cysteines and related methods
#715Devices and methods for facilitating and controlling use of a medication
#716PARTHENOLIDE AND ITS DERIVATIVE FOR USE IN THE TREATMENT OF AXONAL DAMAGE
#717Apparatus for a mass production of monodisperse biodegradeable polymer-based microspheres and a multi-channel forming device incorporatable therein
#718Apparatus for a mass production of monodisperse biodegradable polymer-based microspheres and a multi-channel forming device incorporatable therein
#719Combination HIV therapeutic
#720Reagents and Methods for Cancer Treatment and Prevention
#721Therapeutics targeting IGFBP7 for the treatment or prevention of heart failure and metabolic diseases
#722CDC7 kinase inhibitors and uses thereof
#723Compositions and methods of improved wound healing
#724THERAPEUTIC COMPOSITIONS
#725Acylated glucagon analogue
#726METHODS OF TRACKING SKIN CONDITIONS USING CYCLOLIGNAN COMPOUNDS
#727Miliusanes as antiviral agents
#728Compositions for use in the treatment of tumors resistant to chemotherapy
#729Derivatives of korormicin useful as antibiotics
#730Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
#731PYRANONAPHTHOQUINONE COMPOUNDS AND METHODS OF USE THEREOF
#732Compounds, substrates and methods related to histone deacetylases
#733Compositions and methods to treat niemann-pick disease
#734Preparation of an oil-in-water emulsion for polymer stabilized pharmaceutical formulations
#735PHARMACEUTICAL COMPOSITIONS COMPRISING 0.5 MG DOSE OF SYNTHETIC HUMAN PEPTIDES FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
#736Compositions for use in treating glioblastoma
#737PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS
#738C14-hydroxyl esterified amino acid derivative of triptolide, and preparation method and use thereof
#739Methods of treatment using an interferon gamma inhibitor
#740Use of albiflorin or pharmaceutically acceptable salt for prevention and/or treatment of irritable bowel syndrome
#741Stable cannabinoid formulations
#742Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation
#743Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces
#744Composition and method for improving sleep duration and quality
#745Methods for Modulating Genome Editing
#746Use of flibanserin in the treatment of obesity
#747Compositions and methods for reactivating latent immunodeficiency virus
#748FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES
#749Therapeutic Nanoparticles With High Molecular Weight Copolymers
#750Modulation of Bacterial Quorum Sensing with Synthetic Ligands
#751Treatment of filarial diseases
#752Neprilysin inhibitors
#753β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereof
#754FAS inhibitors and methods associated therewith
#755Polymorph of granaticin B
#756Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders
#757DITERPENOID DERIVATIVES AND METHODS OF USE THEREOF
#758Treatment of solid tumours
#759Ecteinamycin, compositions and uses thereof
#760Soothing composition for animals, comprising at least one fatty acid and nepetalactone
#761Inhibition of proline catabolism for the treatment of cancer and other therapeutic applications
#762Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies
#763TITRATED EXTRACTS OF CYNARA SCOLYMUS FOR USE IN THE TREATMENT OF MESOTHELIOMA
#764Compositions, methods of use, and methods of treatment
#765Use of Z-butylidenephthalide in activating autoimmune system
#766Method for delaying the onset of pulmonary fibrosis or treating pulmonary fibrosis
#767Glutarate compounds for treating ischemia-reperfusion injuries
#768Lymph directing prodrugs
#769Pharmaceutical composition containing Ginkgolide B and Xa factor inhibitor, preparation method thereof and use thereof
#770METHODS OF STIMULATING CELLULAR GROWTH, SYNAPTIC REMODELING AND CONSOLIDATION OF LONG-TERM MEMORY
#771LACTONE COMPOUNDS AND METHODS OF MAKING AND USING SAME
#772Analogs of adenosine monophosphate (AMP) as inhibitors of ubiquitin-like modifier-activating enzyme ATG7
#773TRANSDERMAL PARASITICIDAL FORMULATIONS
#774Pharmaceutical composition containing Ginkgolide B and ADP receptor antagonist, preparation method thereof and use thereof
#775Binding molecules, especially antibodies, binding to L1CAM (CD171)
#776Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis
#777Methods and compositions for the inhibition of Pin1
#778Coordinated metabolic reprogramming in response to productive viral infections
#779Antimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same
#780Methods and compositions for increasing the potency of antifungal agents
#781Compositions and methods for selective GI tract delivery
#782Soft chewable pharmaceutical products
#783Chemical entities that kill senescent cells for use in treating age-related disease
#784Drug-containing particulate composition with cationic agent, associated medical devices, and methods for treatment
#785Compounds for the treatment of HPV-induced carcinoma
#786Methods for increasing red blood cell levels and treating ineffective erythropoiesis
#787Pharmaceutical composition containing Ginkgolide B and blood platelet prostaglandin cyclooxygenase inhibitor and method for preparation thereof and use thereof
#788Controlled drug release liposome compositions and methods thereof
#789METHOD FOR PREVENTING CANCER BY USING PHTHALIDES
#790Method for enhancing the oxygenation level of tissue cells as an alternative method for hyperbaric oxygen therapy
#791METHOD FOR TREATING ALZHEIMER'S DISEASE AND 2, 3-BIPHOSPHOGLYCERATE METABOLISM DISORDER INDUCED
#792Solubility of therapeutic agents
#793Hepatitis B antiviral agents
#794Methods of treatment of malignancies
#795Use of Artemisinin for Treating Tumors Induced by Oncogenic Viruses and for Treating Viral Infections
#796BRYOSTATIN ANALOGS AND USE THEREOF AS ANTIVIRAL AGENTS
#797Pharmaceutical compositions for treating ebola virus disease
#798Compound combinations for attenuation of bacterial virulence
#799Composition and method to treat and alleviate symptoms of hot flashes in a female subject
#800METHODS FOR REDUCING LDL-CHOLESTEROL
#801Aromatic farnesyl compound and application thereof
#802APPLICATION OF ANDROGRAPHOLIDE IN THE PREPARATION OF A PHARMACEUTICAL FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE, ANDROGRAPHOLIDE ENTERIC TARGETING MICROPELLET, AND METHOD FOR PREPARATION THEREOF
#803APPLICATION OF ANDROGRAPHOLIDE IN THE PREPARATION OF A PHARMACEUTICAL FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE, ANDROGRAPHOLIDE ENTERIC TARGETING MICROPELLET, AND METHOD FOR PREPARATION THEREOF
#804Treatment of sickle cell disease
#805Use of butylidenephthalide (Bdph), method of using the same, and method for preparing pharmaceutical composition containing the same
#806METHODS AND COMPOSITIONS FOR TREATMENT OR DIAGNOSIS OF CANCERS RELATED TO GABRA3
#807Compositions and Related Methods For Treating Hyperadrenocorticism
#808Sesquiterpene derivatives and their use in inflammation or cancer treatment
#809METHODS AND COMPOSITIONS FOR TREATMENT OF LIPID STORAGE DISORDERS
#810Use of a composition for lowering cholesterol level in a mammal, a method for its preparation and a product and a food additive comprising said composition
#811Use of composition for modulating angiogenesis
#812Method for determining the risk profile of neoplastic tissue
#813Method for diagnosing subclinical and clinical acute rejection by analysis of predictive gene sets
#814NOVEL ESTROGEN RECEPTOR LIGANDS
#815ARYLNAPHTHALENE LACTONE DERIVATIVES AND METHODS OF MAKING AND USING THEREOF
#816CDC7 kinase inhibitors and uses thereof
#817Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
#818Compounds and methods for inducing chondrogenesis
#819Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts
#820PPAR-gamma activator
#821TREATMENT OF THE COMPLICATIONS OF CHRONIC LIVER DISEASE WITH CASPASE INHIBITORS
#822Small molecule efflux pump inhibitors
#823Solid Oral Pharmaceutical Compositions for Isoxazoline Compounds
#824METHODS FOR MODULATING CANCER CELLS AND STEM CELLS
#825Treprostinil derivative compounds and methods of using same
#826Compositions and methods to treat Niemann-Pick disease
#827Medicinal ambrosia maritima extracts
#828Therapy for constipation
#829Ophthalmic formulations of mycophenolic acid
#830Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof
#831Composition comprising 7-hydroxymatairesinol
#832COMPOSITIONS COMPRISING BOTANICALS, INCLUDING THE USE AND METHOD OF USE THEREOF
#833MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY
#834USES OF BUTYLIDENEPHTHALIDE
#835Edible energy composition
#836Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
#837Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
#838Methods and compositions for treating nephrogenic diabetes insipidus
#839Controlled release composition
#840NEOSORAPHENS
#841Composition and method to treat and alleviate symptoms of hot flashes in a female subject
#842Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders
#843Antiparisitic dihydroazole compounds and compositions comprising same
#844Anthelmintic combinations and methods of use thereof
#845Tricyclic prodrugs
#846Targeted therapeutics
#847METHODS OF REACTIVATING A LATENT HUMAN IMMUNODEFICIENCY VIRUS
#848ANTI-CHOLESTEROLEMIC COMPOUNDS AND METHODS OF USE
#849Therapeutic peptides
#850Stable veterinary anthelmintic formulations
#851Spray-dried solid-in-oil-in-water dispersions for inhalation of active pharmaceutical ingredients
#852Ophthalmic drug delivery method
#853MUSK COMPOSITIONS AND METHODS OF USE THEREOF
#854Musk compositions and methods of use thereof
#855TOPICAL COMPOSITION COMPRISING NATURAL INGREDIENTS FOR BRUISING OR HEMATOMA HEALING ON SKIN AND USE THEREOF
#856Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
#857Uses of sesquiterpene lactone compounds and their derivatives in drugs preparation
#858Use of Lappaol F to inhibit tumor cell growth
#859LKB1 related diagnostics and treatments of cancer
#860Methods and systems for modulating hormones and related methods, agents and compositions
#861Methods and compounds for modulating the secretion or expression of adhesion proteins or angiopoietins of cells
#862Method of treating MYC-amplified tumors with RNA-polymerase II inhibitors
#863Methods of producing cancer targeting compounds
#864Methods of producing cancer treating compounds
#865Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
#866Treatment of viral infections by modulation of host cell metabolic pathways
#867TOFA analogs useful in treating dermatological disorders or conditions
#868Methods and compositions for preventing and treating auditory dysfunctions
#869Use of CD83 in Combination Therapies
#870Method for providing an increased expression of telomerase, brain-derived neurotrophic factor, stromal cell-derived factor-1, CXC chemokine receptor 4, and/or immune regulatory factor of stem cell
#871Use of atractylenolide compound or its derivatives and a medicament for inhibiting platelet aggregation
#872Targeted nanocarriers for the administration of immunosuppressive agents
#873Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation
#874Agent for inhibiting odor of pyrazine derivatives
#875CANCER TREATMENTS USING COMBINATIONS OF MEK TYPE 1 AND ERK INHIBITORS
#876Peloruside analogs
#877Method for enhancing therapeutic effect of stem cells
#878Method for preparing an anthelmintic composition, anthelmintic composition, veterinary treatment method and anthelmintic treatment method
#879NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF BACTERIAL INFECTIOUS DISEASES
#880METHOD FOR PRODUCING AVENACIOLIDES AND USES THEREOF
#881Cytotoxin compounds and methods of isolation
#882METHODS FOR PROGNOSING THE ABILITY OF A ZEARALENONE ANALOG COMPOUND TO TREAT CANCER
#883Anilino podophyllin derivative having antitumor activity, method for preparation thereof, and use thereof
#884COMBINATION THERAPY INCLUDING AN MDM2 INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF CANCERS
#885Combination of selected analgesics and COX-II inhibitors
#886Use of 15-benzylidence-14-deoxy-11, 12 -dehyroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virus
#887Trail enhancers for the selective killing of cancer cells
#888Methods of treatment using extracts of
#889Trace elements
#890Compositions and methods of inhibiting N-acylethanolamine-hydrolyzing acid amidase
#891Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
#892Compositions, methods of use, and methods of treatment
#893Monoacylglycerols for use in conjunction with a lipase inhibitor and/or diets low in fat and/or calories
#894HCD formulation for cancer treatment
#895Vaults engineered for hydrophobic drug delivery
#896DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA)
#897Method for cancer cell reprogramming
#898Parasiticidal compositions comprising multiple active agents, methods and uses thereof
#899ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS
#900Glycan therapeutics and related methods thereof